Researchers have used advanced genetic sequencing on a Brisbane family to identify a gene mutation linked to ulcerative colitis, a type of inflammatory bowel condition, sparking hopes of new ...

New research reveals cannabis-infused drinks significantly slash alcohol consumption, offering a promising, lower-risk alternative for a healthier lifestyle.

Praxis Precision Medicines, Inc. ( PRAX) TD Cowen 46th Annual Health Care Conference March 2, 2026 11:50 AM EST ...

A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose.

WASHINGTON — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval of new drugs, the latest change from Trump administration officials ...

Massive study finds most statin side effects aren’t caused by the drugs Results challenge years of fear and misinformation surrounding these widely used heart-protecting drugs. Date: February 15, 2026 ...

New research suggests that weight-loss drugs can help prevent vision loss as patients age, but there’s a major caveat. GLP-1 weight-loss drugs linked to reduced risk of age-related macular ...

SAN FRANCISCO, Feb 11 (Reuters) - Among early users of Novo Nordisk's (NOVOb.CO), opens new tab new Wegovy weight-loss pill, 36% had no prior experience taking a GLP-1 medication, a new nationwide ...

A real-world comparison of two androgen receptor pathway inhibitors (ARPIs) for advanced prostate cancer showed a significant difference in overall survival (OS). Patients with metastatic ...

The long list of side effects marked on the packaging of statins can be a turn-off for those who might benefit from the cholesterol-lowering drugs. But a new study found only a few of those side ...

Ozempic, Mounjaro, and Zepbound can drive impressive weight loss, but stopping them is often followed by rapid weight regain. Researchers found that people regain weight faster after quitting these ...

Risk of recurrent major adverse limb events was lower in diabetes patients taking GLP-1 agents compared with DPP-4 inhibitors. Reduction of limb events was most significant for major amputations, ...